Drug intelligence / Profile preview

cypermethrin

Development stage: Unknown
Lead developer: FMC Corporation
Modality: Small Molecules
Administration: Topical

Overview

Cypermethrin is a synthetic pyrethroid insecticide and acaricide widely used in agriculture and domestic pest control. It acts as a fast-acting neurotoxin in insects by disrupting the function of voltage-gated sodium channels (VGSC), leading to prolonged channel opening, hyper-excitation of the nervous system, paralysis, and death. Cypermethrin also modulates other ion channels (chloride, calcium, potassium) and neurotransmitter systems. It is non-systemic and non-volatile; its effects are primarily through contact or ingestion. In veterinary medicine, it is used to control ectoparasites on cattle, sheep, poultry, and companion animals[1][3][4][5][6][8].

Brand names: RaidOrthoCombatBaygon
Other names: CP

Targets

NaV (Voltage-gated sodium channels)Maxi-Cl (Maxi chloride channel)

Beyond the preview

Go deeper on cypermethrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on cypermethrin.

Explore the full profile